SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma gains on plan to sell its step-down subsidiary at Kenya

01 Jun 2015 Evaluate

Bliss GVS Pharma is currently trading at Rs 125.00, up by 0.90 points or 0.73% from its previous closing of Rs. 124.10 on the BSE.

The scrip opened at Rs 127.20 and has touched a high and low of Rs 130.00 and Rs 123.80 respectively. So far 44317 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 145.70 on 13-Apr-2015 and a 52 week low of Rs. 39.50 on 30-May-2014.

Last one week high and low of the scrip stood at Rs 130.00 and Rs. 117.30 respectively. The current market cap of the company is Rs. 1286.24 crore.

The promoters holding in the company stood at 64.95% while Institutions and Non-Institutions held 4.73% and 30.33% respectively.

Bliss GVS Pharma has received an approval for the sale of step-down subsidiary ‘Surgimed Pharma’ located at Kenya. The board of directors at their meeting held on May 29, 2015 has approved for the same.

Bliss GVS Pharma manufactures wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.

Bliss GVS Pharma Share Price

447.20 7.50 (1.71%)
16-Jun-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.80
Dr. Reddys Lab 1275.10
Cipla 1374.20
Zydus Lifesciences 1075.60
Lupin 2271.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: